{"text": ["5", "Biotech", "IPOs", "to", "Watch", "in", "April"], "created_at": "2018-04-17 23:10:53"}
{"text": ["5", "Biotech", "IPOs", "to", "Watch", "in", "April"], "created_at": "2018-04-17 23:10:53"}
{"text": ["Glaxo,", "Novartis", "Join", "$4", "Billion", "Gates-Led", "Push", "to", "Fight", "Malaria"], "created_at": "2018-04-17 23:01:00"}
{"text": ["Novartis\u2019s", "Innovative", "Medicines", "Segment", "in", "1Q18"], "created_at": "2018-04-17 16:40:02"}
{"text": ["What's", "in", "Store", "for", "Novartis", "(NVS)", "This", "Earnings", "Season?"], "created_at": "2018-04-17 16:15:57"}
{"text": ["What's", "in", "Store", "for", "Novartis", "(NVS)", "This", "Earnings", "Season?"], "created_at": "2018-04-17 16:15:57"}
{"text": ["Novartis\u2019s", "1Q18:", "Analysts", "Expect", "Revenue", "Growth"], "created_at": "2018-04-17 15:10:02"}
{"text": ["What&apos;s", "in", "Store", "for", "Novartis", "(NVS)", "This", "Earnings", "Season?"], "created_at": "2018-04-17 13:55:01"}
{"text": ["Expectations", "from", "Novartis\u2019s", "1Q18", "Earnings"], "created_at": "2018-04-17 13:36:50"}
{"text": ["Risankizumab", "Could", "Be", "AbbVie\u2019s", "Long-Term", "Growth", "Driver"], "created_at": "2018-04-17 13:02:26"}
{"text": ["The", "Swiss", "Stock", "Market", "Rebounded", "As", "Syria", "Concerns", "Relax"], "created_at": "2018-04-17 12:13:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Rebounded", "As", "Syria", "Concerns", "Relax"], "created_at": "2018-04-17 12:13:00"}
{"text": ["Novartis", "tender", "offer", "for", "AveXis", "commences"], "created_at": "2018-04-17 05:01:01"}
{"text": ["Novartis", "Unit", "Commences", "Tender", "Offer", "For", "AveXis", "Stock", "-", "Quick", "Facts"], "created_at": "2018-04-17 01:18:00"}
{"text": ["Novartis", "Unit", "Commences", "Tender", "Offer", "For", "AveXis", "Stock", "-", "Quick", "Facts"], "created_at": "2018-04-17 01:18:00"}
